FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751391351> ?p ?o ?g. }

• W2751391351 endingPage "430" @default.
• W2751391351 startingPage "419" @default.
• W2751391351 abstract "Background/Aims: The present study was designed to investigate the expression of multidrug resistance (MDR)-related genes, verify the synergistic effects of baicalin and Adriamycin (ADM) and investigate the related mechanisms in ADM-resistant leukaemic HL-60/ADM cells. Methods: We used a HL-60/ADM cell line. Cytotoxicity and flow cytometry assays were employed to verify the cytotoxic effects of baicalin. Real-time polymerase chain reaction and Western blotting assays were used to assess the expression of MDR-related genes and the changes in gene expression (both MDR-related and PI3K/Akt pathway-related) induced by administration of baicalin. Results: We found that only multidrug resistance protein 1 (MRP1), lung resistance-related protein (LRP) and Bcl-2 genes were expressed in both HL-60 and HL-60/ADM cells. HL-60/ADM cells exhibited significantly higher expression (p < 0.05). We also observed that low-dose baicalin (5 and 10 µmol/L) can induce growth inhibition and apoptotic effects on HL-60/ADM cells by increasing the intracellular accumulation of ADM. The synergistic effect of baicalin and ADM was verified. Concerning the potential mechanisms involved in this process, we showed that baicalin down-regulated the expression of several MDR-related and PI3K/Akt pathway-related genes. Conclusions: We confirmed the increased expression of MRP1, LRP and Bcl-2 genes in HL-60/ADM cells compared to regular HL-60 cells, which are recommended for future investigation on MDR. The present study provided evidence of the synergistic effect of baicalin and ADM in HL-60/ADM cells. Therefore, baicalin may be considered as a potential therapeutic agent against resistant leukaemia. Suppression of the PI3K/Akt signalling pathway, followed by inhibition of the expression of MDR-related genes may be a common mechanism in combination treatments with ADM for the reduction of resistance to ADM." @default.
• W2751391351 created "2017-09-15" @default.
• W2751391351 creator A5022511548 @default.
• W2751391351 creator A5030710878 @default.
• W2751391351 creator A5036140812 @default.
• W2751391351 creator A5045594996 @default.
• W2751391351 creator A5057401157 @default.
• W2751391351 creator A5057855713 @default.
• W2751391351 creator A5066981637 @default.
• W2751391351 creator A5075744266 @default.
• W2751391351 date "2017-01-01" @default.
• W2751391351 modified "2023-09-24" @default.
• W2751391351 title "Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells" @default.
• W2751391351 cites W1538993069 @default.
• W2751391351 cites W1590322112 @default.
• W2751391351 cites W1864885605 @default.
• W2751391351 cites W1980483408 @default.
• W2751391351 cites W1984699508 @default.
• W2751391351 cites W1996694532 @default.
• W2751391351 cites W1998809452 @default.
• W2751391351 cites W2004944892 @default.
• W2751391351 cites W2023948074 @default.
• W2751391351 cites W2034485827 @default.
• W2751391351 cites W2041697397 @default.
• W2751391351 cites W2119860356 @default.
• W2751391351 cites W2122649422 @default.
• W2751391351 cites W2134387658 @default.
• W2751391351 cites W2152728586 @default.
• W2751391351 cites W2167900923 @default.
• W2751391351 cites W2339625610 @default.
• W2751391351 cites W2513407592 @default.
• W2751391351 cites W2533005202 @default.
• W2751391351 cites W2561353042 @default.
• W2751391351 cites W2588844900 @default.
• W2751391351 doi "https://doi.org/10.1159/000480420" @default.
• W2751391351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28869936" @default.
• W2751391351 hasPublicationYear "2017" @default.
• W2751391351 type Work @default.
• W2751391351 sameAs 2751391351 @default.
• W2751391351 citedByCount "10" @default.
• W2751391351 countsByYear W27513913512018 @default.
• W2751391351 countsByYear W27513913512019 @default.
• W2751391351 countsByYear W27513913512020 @default.
• W2751391351 countsByYear W27513913512021 @default.
• W2751391351 countsByYear W27513913512022 @default.
• W2751391351 countsByYear W27513913512023 @default.
• W2751391351 crossrefType "journal-article" @default.
• W2751391351 hasAuthorship W2751391351A5022511548 @default.
• W2751391351 hasAuthorship W2751391351A5030710878 @default.
• W2751391351 hasAuthorship W2751391351A5036140812 @default.
• W2751391351 hasAuthorship W2751391351A5045594996 @default.
• W2751391351 hasAuthorship W2751391351A5057401157 @default.
• W2751391351 hasAuthorship W2751391351A5057855713 @default.
• W2751391351 hasAuthorship W2751391351A5066981637 @default.
• W2751391351 hasAuthorship W2751391351A5075744266 @default.
• W2751391351 hasBestOaLocation W27513913511 @default.
• W2751391351 hasConcept C104317684 @default.
• W2751391351 hasConcept C133936738 @default.
• W2751391351 hasConcept C153911025 @default.
• W2751391351 hasConcept C179998833 @default.
• W2751391351 hasConcept C185592680 @default.
• W2751391351 hasConcept C190283241 @default.
• W2751391351 hasConcept C2780113650 @default.
• W2751391351 hasConcept C43617362 @default.
• W2751391351 hasConcept C501593827 @default.
• W2751391351 hasConcept C502942594 @default.
• W2751391351 hasConcept C54355233 @default.
• W2751391351 hasConcept C553184892 @default.
• W2751391351 hasConcept C55493867 @default.
• W2751391351 hasConcept C75217442 @default.
• W2751391351 hasConcept C79879829 @default.
• W2751391351 hasConcept C81885089 @default.
• W2751391351 hasConcept C85265743 @default.
• W2751391351 hasConcept C86554907 @default.
• W2751391351 hasConcept C86803240 @default.
• W2751391351 hasConcept C98274493 @default.
• W2751391351 hasConceptScore W2751391351C104317684 @default.
• W2751391351 hasConceptScore W2751391351C133936738 @default.
• W2751391351 hasConceptScore W2751391351C153911025 @default.
• W2751391351 hasConceptScore W2751391351C179998833 @default.
• W2751391351 hasConceptScore W2751391351C185592680 @default.
• W2751391351 hasConceptScore W2751391351C190283241 @default.
• W2751391351 hasConceptScore W2751391351C2780113650 @default.
• W2751391351 hasConceptScore W2751391351C43617362 @default.
• W2751391351 hasConceptScore W2751391351C501593827 @default.
• W2751391351 hasConceptScore W2751391351C502942594 @default.
• W2751391351 hasConceptScore W2751391351C54355233 @default.
• W2751391351 hasConceptScore W2751391351C553184892 @default.
• W2751391351 hasConceptScore W2751391351C55493867 @default.
• W2751391351 hasConceptScore W2751391351C75217442 @default.
• W2751391351 hasConceptScore W2751391351C79879829 @default.
• W2751391351 hasConceptScore W2751391351C81885089 @default.
• W2751391351 hasConceptScore W2751391351C85265743 @default.
• W2751391351 hasConceptScore W2751391351C86554907 @default.
• W2751391351 hasConceptScore W2751391351C86803240 @default.
• W2751391351 hasConceptScore W2751391351C98274493 @default.
• W2751391351 hasIssue "1" @default.
• W2751391351 hasLocation W27513913511 @default.

• next